Posted by Michael Wonder on 01 May 2017
Cancer fund failure highlights the dilemma of drug pricing
1 May 2017 - The challenge is to keep treatments affordable but still encourage innovation.
The Cancer Drugs Fund was a trophy for politicians, a bottomless trough for public money and, worst of all, a tragedy for patients. The fund was set up in 2010 by the UK government as a way of expediting access to high-cost medicines for patients who did not have time on their side.
It was supposed to cost £50 million a year but ended up swallowing £1.3 billion over six years.
